# Skyward Specialty Insurance Group, Inc.: Form 10-Q for the period ended Mar 31, 2024

- Company: [Skyward Specialty Insurance Group, Inc.](/companies/skwd.md) (CIK 1519449)
- Form: 10-Q
- Filed: 2024-05-03
- Accepted by EDGAR: May 3, 2024, 12:53 ET
- Period: 2024-03-31
- Accession: 0001519449-24-000024
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1519449/000151944924000024/skwd-20240331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1519449/000151944924000024/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2024-01-01 to 2024-03-31 | $2.0m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Interest expense | 3 months, 2024-01-01 to 2024-03-31 | $2.7m | us-gaap:InterestExpense |
| Income tax | 3 months, 2024-01-01 to 2024-03-31 | $10.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2024-01-01 to 2024-03-31 | $36.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2024-01-01 to 2024-03-31 | $0.90 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2024-01-01 to 2024-03-31 | $0.94 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2024-01-01 to 2024-03-31 | 41,085,136 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2024-01-01 to 2024-03-31 | $94.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2024-01-01 to 2024-03-31 | $260.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2024-03-31 | $85.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | at 2024-03-31 | $3.19bn | us-gaap:Assets |
| Total liabilities | at 2024-03-31 | $2.49bn | us-gaap:Liabilities |
| Shareholders' equity | at 2024-03-31 | $692.3m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 29,919 characters.

*The term “Skyward Specialty” as used below refers only to Skyward Specialty Insurance Group, Inc. and the terms “our Company,” “we,” “us,” and “our” as used below refer to Skyward Specialty Insurance Group and its consolidated subsidiaries. The term “first quarter” as used below refers to the three months ended March 31 for the time period then ended. We discuss certain key metrics which provide useful information about our business and the operational factors underlying our financial performance. Many of these metrics are generally standard among insurance companies and help to provide comparability with our peers. Select insurance, accounting, operating and financial terms for Skyward Specialty are defined in the sections entitled “Select Insurance and Financial Terms” and “Key Operating and Financial Metrics” included in our Annual Report on Form 10-K for the year ended December 31, 2023 (the “2023 Form 10-K”).*

*The discussion and analysis below include certain forward-looking statements that are subject to risks, uncertainties and other factors described in "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2023. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of many factors.*

*The results of operations for the three months ended March 31, 2024 are not necessarily indicative of the results that may be expected for the full year ended December 31, 2024, or for any other future period. The following discussion should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto included in Part I, Item 1 of this Quarterly Report, and in conjunction with our audited consolidated financial statements and the notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2023.*

*The accompanying condensed consolidated financial statements and related notes have been prepared in accordance with United States (“U.S.”) generally accepted accounting principles (“GAAP”).*

### Overview

Founded in 2006, Skyward Specialty is a specialty insurance holding company incorporated in Delaware. We have one reportable segment through which we offer a broad array of commercial property and casualty products and solutions on a non-admitted (or E&S) and admitted basis, predominantly in the United States. We focus our business on markets that are underserved, dislocated and/or for which standard insurance coverages are insufficient or inadequate to meet the needs of businesses, including our customers and prospective customers operating in these markets. Our customers typically require highly specialized, customized underwriting solutions and claims capabilities. As such, we develop and deliver tailored insurance products and services to address each of the niche markets we serve.

Each of our eight distinct underwriting divisions has dedicated underwriting leadership supported by high-quality technical staff with deep experience in their respective niches. We believe this structure and expertise allows us to serve the needs of our customers effectively and be a value-add partner to our distributors, while earning attractive risk-adjusted returns.

All of our insurance company subsidiaries are group rated and have financial strength ratings of “A-” (Excellent) with positive outlook from the A.M. Best Company.

### Results of Operations

The following table summarizes our results for the three months ended March 31, 2024 and 2023:

*($ in thousands)*

|  | Three months ended March 31, 2024 | 2023 |
| --- | ---: | ---: |
| Gross written premiums | **$458,620** | $360,498 |
| Ceded written premiums | **(171,520)** | (158,357) |
| Net written premiums | **$287,100** | $202,141 |
| Net earned premiums | **$236,342** | $182,831 |
| Commission and fee income | **2,026** | 1,492 |
| Losses and LAE | **143,914** | 114,900 |
| Underwriting, acquisition and insurance expenses | **69,774** | 51,655 |
| Underwriting income(1) | **$24,680** | $17,768 |
| Net investment income | **$18,297** | $4,646 |
| Net investment gains | **$8,303** | $961 |
| Income before income taxes | **$46,977** | $19,722 |
| Net income | **$36,784** | $15,556 |
| Adjusted operating income(1) | **$30,974** | $15,486 |
| Loss and LAE ratio | **60.9%** | 62.8% |
| Expense ratio | **28.7%** | 27.4% |
| Combined ratio | **89.6%** | 90.2% |
| Adjusted loss and LAE ratio(1) | **61.0%** | 62.9% |
| Expense ratio | **28.7%** | 27.4% |
| Adjusted combined ratio(1) | **89.7%** | 90.3% |
| Annualized return on equity | **21.7%** | 13.4% |
| Annualized return on tangible equity(1) | **25.0%** | 16.6% |
| Annualized adjusted return on equity(1) | **18.3%** | 13.3% |
| Annualized adjusted return on tangible equity(1) | **21.1%** | 16.5% |
| (1) See “Reconciliation of Non-GAAP Financial Measures” in this Item 2 |  |  |

### Reconciliation of Non-GAAP Financial Measures

#### Adjusted Operating Income

The following table provides a reconciliation of adjusted operating income to net income for the three months ended March 31, 2024 and 2023:

*($ in thousands)*

|  | Three months ended March 31, 2024 Pre-tax | After-tax | 2023 Pre-tax | After-tax |
| --- | ---: | ---: | ---: | ---: |
| Income as reported | **$46,977** | **$36,784** | $19,722 | $15,556 |
| Less (add): |  |  |  |  |
| Net impact of LPT | **241** | **190** | 242 | 191 |
| Net investment gains | **8,303** | **6,559** | 961 | 759 |
| Other expenses | **(1,188)** | **(939)** | (1,114) | (880) |
| **Adjusted operating income** | **$39,621** | **$30,974** | $19,633 | $15,486 |

25

#### Underwriting Income

The following table provides a reconciliation of underwriting income to income before federal income tax for the three months ended March 31, 2024 and 2023:

*($ in thousands)*

|  | Three months ended March 31, 2024 | 2023 |
| --- | ---: | ---: |
| Income before federal income tax expense | **$46,977** | $19,722 |
| Add: |  |  |
| Interest expense | **2,727** | 2,152 |
| Amortization expense | **388** | 387 |
| Other expenses | **1,188** | 1,114 |
| Less: |  |  |
| Net investment income | **18,297** | 4,646 |
| Net investment gains | **8,303** | 961 |
| **Underwriting income** | **$24,680** | $17,768 |

#### Adjusted Loss Ratio / Adjusted Combined Ratio

The following table provides a reconciliation of the adjusted loss and LAE ratio and adjusted combined ratio to the loss and LAE ratio and combined ratio for the three months ended March 31, 2024 and 2023:

*($ in thousands)*

|  | Three months ended March 31, 2024 | 2023 |
| --- | ---: | ---: |
| Net earned premiums | **$236,342** | $182,831 |
| Losses and LAE | **143,914** | 114,900 |
| Pre-tax net impact of loss portfolio transfer | **241** | 242 |
| Adjusted losses and LAE | **$144,155** | $115,142 |
| Loss ratio | **60.9%** | 62.8% |
| Less: Net impact of LPT | **(0.1)%** | (0.1)% |
| **Adjusted loss ratio** | **61.0%** | 62.9% |
| Combined ratio | **89.6%** | 90.2% |
| Less: Net impact of LPT | **(0.1)%** | (0.1)% |
| **Adjusted combined ratio** | **89.7%** | 90.3% |

#### Tangible Stockholders’ Equity

The following table provides a reconciliation of tangible stockholders’ equity to stockholders’ equity for the periods ended March 31, 2024 and 2023:

*($ in thousands)*

|  | 2024 | 2023 |
| --- | ---: | ---: |
| Stockholders' equity | **$692,272** | $507,146 |
| Less: Goodwill and intangible assets | **88,137** | 89,503 |
| **Tangible stockholders' equity** | **$604,135** | $417,643 |

26

#### Annualized Adjusted Return on Equity

The following table provides a reconciliation of annualized adjusted return on equity to annualized return on equity for the three months ended March 31, 2024 and 2023:

*($ in thousands)*

|  | Three months ended March 31, 2024 | 2023 |
| --- | ---: | ---: |
| Numerator: annualized adjusted operating income | **$123,896** | $61,943 |
| Denominator: average stockholders’ equity | **$676,652** | $464,404 |
| Annualized adjusted return on equity | **18.3%** | 13.3% |

#### Annualized Return on Tangible Equity

Annualized return on tangible equity for the three months ended March 31, 2024 and 2023 reconciles to annualized return on equity as follows:

*($ in thousands)*

|  | Three months ended March 31, 2024 | 2023 |
| --- | ---: | ---: |
| Numerator: annualized net income | **$147,136** | $62,224 |
| Denominator: average tangible stockholders’ equity | **$588,366** | $374,718 |
| Annualized return on tangible equity | **25.0%** | 16.6% |

#### Annualized Adjusted Return on Tangible Equity

Annualized adjusted return on tangible equity for the three months ended March 31, 2024 and 2023 reconciles to annualized return on equity as follows:

*($ in thousands)*

|  | Three months ended March 31, 2024 | 2023 |
| --- | ---: | ---: |
| Numerator: annualized adjusted operating income | **$123,896** | $61,943 |
| Denominator: average tangible stockholders’ equity | **$588,366** | $374,718 |
| Annualized adjusted return on tangible equity | **21.1%** | 16.5% |

### Underwriting Results

#### Premiums

The following table presents gross written premiums by underwriting division for the three months ended March 31, 2024 and 2023:

*($ in thousands)*

|  | Three months ended March 31, 2024 | 2023 | Change | % Change |
| --- | ---: | ---: | ---: | ---: |
| Global Property & Agriculture | **$100,633** | $74,340 | $26,293 | 35.4% |
| Industry Solutions | **78,259** | 67,633 | 10,626 | 15.7% |
| Captives | **68,408** | 46,080 | 22,328 | 48.5% |
| Programs | **52,178** | 48,699 | 3,479 | 7.1% |
| Professional Lines | **42,239** | 33,172 | 9,067 | 27.3% |
| Transactional E&S | **42,195** | 29,617 | 12,578 | 42.5% |
| Accident & Health | **40,901** | 36,013 | 4,888 | 13.6% |
| Surety | **33,842** | 24,701 | 9,141 | 37.0% |
| Total gross written premiums(1) | **$458,655** | $360,255 | $98,400 | 27.3% |
| (1) Excludes exited business |  |  |  |  |

The increase in gross written premiums for the first quarter of 2024, when compared to the same 2023 period, was primarily driven by double-digit premium growth primarily from our captives, transactional E&S, surety, global property

& agriculture and professional lines underwriting divisions. The double-digit premium growth was due to new business and increased rates.

Net written premiums for the first quarter of March 31, 2024 were $287.1 million, an increase of $85.0 million or 42.0%, when compared to the same 2023 period.

Net earned premiums for the three months ended March 31, 2024 were $236.3 million, an increase of $53.5 million, or 29.3%, when compared to the same 2023 period. The increases in net earned premiums were primarily driven by the same reasons that drove the increases in gross written premiums discussed above.

For additional information regarding our reinsurance programs, see the “Reinsurance” discussion included in this Item 2.

#### Losses and LAE

The following table sets forth the components of the loss and LAE ratios and adjusted loss and LAE ratios for the three months ended March 31, 2024 and 2023:

*($ in thousands)*

| Losses and LAE: | Three months ended March 31, 2024 Losses and LAE | % of Net Earned Premiums | 2023 Losses and LAE | % of Net Earned Premiums |
| --- | ---: | ---: | ---: | ---: |
| Non-cat loss and LAE(1) | **$143,155** | **60.6%** | $111,902 | 61.1% |
| Cat loss and LAE(1) | **1,000** | **0.4%** | 3,240 | 1.8% |
| Prior accident year development - LPT | **(241)** | **(0.1)%** | (242) | (0.1)% |
| Total losses and LAE | **$143,914** | **60.9%** | $114,900 | 62.8% |
| Adjusted losses and LAE(2): |  |  |  |  |
| Non-cat loss and LAE(1) | **$143,155** | **60.6%** | $111,902 | 61.1% |
| Cat loss and LAE(1) | **1,000** | **0.4%** | 3,240 | 1.8% |
| Total adjusted losses and LAE(2) | **$144,155** | **61.0%** | $115,142 | 62.9% |
| (1) Current accident year |  |  |  |  |
| (2) See "Reconciliation of Non-GAAP Financial Measures" included in this Item 2 |  |  |  |  |

The loss ratio for the first quarter of 2024 improved 1.9 points when compared to the same 2023 period. The first quarter of 2024 was minimally impacted by catastrophe losses, while the first quarter of 2023 was impacted by wind and hail events, including tornadoes, which added 1.8 points to the 2023 loss ratio. The non-cat loss and LAE ratio improved 0.5 points when compared to the same 2023 period, primarily driven by the shift in the mix of business.

#### Expense Ratio

The following table sets forth the components of the expense ratios for the three months ended March 31, 2024 and 2023:

*($ in thousands)*

|  | Three months ended March 31, 2024 Expenses | % of Net Earned Premiums | 2023 Expenses | % of Net Earned Premiums |
| --- | ---: | ---: | ---: | ---: |
| Net policy acquisition expenses | **$31,977** | **13.6%** | $21,235 | 11.6% |
| Other operating and general expenses | **37,797** | **16.0%** | 30,420 | 16.6% |
| Underwriting, acquisition and insurance expenses | **69,774** | **29.6%** | 51,655 | 28.2% |
| Less: commission and fee income | **(2,026)** | **(0.9%)** | (1,492) | (0.8%) |
| **Total net expenses** | **$67,748** | **28.7%** | $50,163 | 27.4% |

The expense ratio for the first quarter of 2024 increased 1.3 points when compared to the same 2023 period, primarily driven by the business mix shift.

The expense ratios for the first quarter of 2024 and 2023, respectively, exclude the impact of IPO related stock compensation and secondary offering expenses, which are reported in other expenses in our condensed consolidated statements of operations and comprehensive income.

#### Investment Results

Beginning January 1, 2024 we simplified the investment portfolio classifications to align with our strategy and the underlying risk characteristics of the portfolio. The prior period has been reclassified to conform to the current period presentation.

The following table sets forth the components of net investment income and net investment gains (losses) for the three months ended March 31, 2024 and 2023:

*$ in thousands*

|  | Three months ended March 31, 2024 | 2023 |
| --- | ---: | ---: |
| Short-term investments & cash and cash equivalents | **$5,088** | $1,776 |
| Fixed income | **12,478** | 7,461 |
| Equities | **627** | (2) |
| Alternative and strategic investments | **104** | (4,589) |
| Net investment income | **$18,297** | $4,646 |
| Net unrealized gains on securities still held | **$8,991** | $3,767 |
| Net realized losses | **(688)** | (2,806) |
| Net investment gains | **$8,303** | $961 |

Net investment income for the first quarter of 2024 increased $13.7 million when compared to the same 2023 period.

The increase in income from our fixed income portfolio for the first quarter of 2024, when compared to the same 2023 period, was due to (i) a larger asset base as we continued to increase our allocation to this part of our investment portfolio and (ii) a higher book yield of 4.7% at March 31, 2024 compared to 4.0% at March 31, 2023. The increase in income from short-term investments & cash and cash equivalents for the first quarter of 2024, when compared to the same 2023 period, was due to higher investment yields and a larger asset base. The fair value of our alternative and strategic investments portfolio for the first quarter of 2024 increased when compared to the same 2023 period, which was impacted by a decline in the fair value of limited partnership investments.

When a fixed maturity has been determined to have an impairment, the impairment charge is separated into an amount representing the credit loss, which is recognized in earnings as a realized loss and on the balance sheet as an allowance for credit losses netted with the amortized cost of fixed maturities. Future increases in fair value, if related to credit factors, are recognized through earnings limited to the amount previously recognized as an allowance for credit losses. The amount related to non-credit factors is recognized in accumulated other comprehensive income and future increases or decreases in fair value, if not credit losses, are included in accumulated other comprehensive (loss) income. We reviewed our available-for-sale fixed maturities at March 31, 2024 and determined that no credit impairment existed in the gross unrealized holding losses. See Note 2, “Investments” to our condensed consolidated financial statements included in Item 1 of this Form 10-Q for additional information.

### Investments

#### Composition of Investment Portfolio

The following table sets forth the components of our investment portfolio at carrying value at March 31, 2024 and December 31, 2023:

*($ in thousands)*

|  | 2024 Carrying Value | % of Total | 2023 Carrying Value | % of Total |
| --- | ---: | ---: | ---: | ---: |
| Cash and cash equivalents | **$85,059** | **4.8%** | $65,891 | 3.9% |
| Short-term investments | **$297,932** | **16.9%** | $270,259 | 16.1% |
| Fixed income | **1,109,484** | **63.1%** | 1,067,721 | 63.6% |
| Equities | **117,083** | **6.7%** | 118,249 | 7.0% |
| Alternative and strategic investments | **148,707** | **8.5%** | 157,458 | 9.4% |
| Total portfolio | **$1,758,265** | **100.0%** | $1,679,578 | 100.0% |

29

#### Fixed income

Our fixed income portfolio primarily consists of investment grade fixed income securities, which are predominantly highly-rated and liquid bonds, and commercial mortgage loans.

The following table sets forth the components of our fixed income securities at March 31, 2024 and December 31, 2023:

*($ in thousands)*

|  | 2024 Carrying Value | % of Total | 2023 Carrying Value | % of Total |
| --- | ---: | ---: | ---: | ---: |
| U.S. government securities | **$35,566** | **3.2%** | $44,166 | 4.1% |
| Corporate securities and miscellaneous | **415,756** | **37.5%** | 383,420 | 35.9% |
| Municipal securities | **95,817** | **8.6%** | 92,778 | 8.7% |
| Residential mortgage-backed securities | **283,014** | **25.5%** | 281,626 | 26.4% |
| Commercial mortgage-backed securities | **30,526** | **2.8%** | 29,934 | 2.8% |
| Other asset-backed securities | **204,496** | **18.4%** | 185,727 | 17.4% |
| Total fixed income portfolio, available-for-sale | **1,065,175** | **96.0%** | 1,017,651 | 95.3% |
| Commercial mortgage loans | **$44,309** | **4.0%** | $50,070 | 4.7% |
| Total fixed income portfolio | **$1,109,484** | **100.0%** | $1,067,721 | 100.0% |

The weighted average credit rating of our available-for-sale fixed income portfolio was “AA-” by Standard & Poor’s Financial Services, LLC (“Standard & Poor’s”) at March 31, 2024 and December 31, 2023. The following table sets forth the credit quality of our available-for-sale fixed income portfolio at March 31, 2024 and December 31, 2023, as rated by Standard & Poor’s or equivalent designation:

*($ in thousands)*

|  | 2024 Fair Value | % of Total | 2023 Fair Value | % of Total |
| --- | ---: | ---: | ---: | ---: |
| AAA | **$478,029** | **44.9%** | $493,252 | 48.6% |
| AA | **118,290** | **11.1%** | 105,906 | 10.4% |
| A | **272,004** | **25.5%** | 233,487 | 22.9% |
| BBB | **173,597** | **16.3%** | 154,096 | 15.1% |
| BB and Lower | **23,255** | **2.2%** | 30,910 | 3.0% |
| Total fixed income portfolio, available-for-sale | **$1,065,175** | **100.0%** | $1,017,651 | 100.0% |

Our commercial mortgage loans are primarily senior loans on real estate across the U.S.

The average duration of our fixed income portfolio was approximately 4.18 years and 4.24 years, respectively, as of March 31, 2024 and December 31, 2023.

#### Equities

The equities portfolio primarily consists of domestic preferred stocks, common equities, exchange traded funds, limited partnerships, limited liability corporations and other types of equity interests, 100.0% of which are publicly traded.

#### Alternative and strategic investments

Alternative investments consists of promissory notes, limited partnerships, joint ventures and equity interests. The underlying investments are primarily floating rate senior secured loans, comprised of short duration, collateralized, asset-oriented credit investments. The limited partnerships and joint ventures are subject to future increases or decreases in asset value as asset values are monetized and the income is distributed. At March 31, 2024 and December 31, 2023, 78.9% and 77.8%, respectively, of the alternative investments were managed by Arena Investors, LPA which is affiliated with Westaim, our largest stockholder. Strategic investments consists of equity interests in private entities within the insurance industry.

### Other Items

#### Income Taxes

Income tax expense for the three months ended March 31, 2024 was $10.2 million compared to $4.2 million for the same 2023 period. Our effective tax rate for the three months ended March 31, 2024 was 21.7%, compared to 21.1% for the same 2023 period. For additional information, see Note 7 of our condensed consolidated financial statements included in Item 1 of this Form 10-Q.

### Liquidity and Capital Resources

#### Sources and Uses of Funds

Our most significant source of cash is from premiums received from our insureds, which, for most policies, we receive at the beginning of the coverage period, net of the related commission amount for the policies. Our most significant cash outflow is for claims that arise when a policyholder incurs an insured loss. Because the payment of claims occurs after the receipt of the premium, often years later, we invest the cash in various investment securities that generally earn interest and dividends. We also use cash to pay for operating expenses such as salaries, rent and taxes and capital expenditures such as technology systems. We use reinsurance to manage the risk that we take on our policies. We cede, or pay out, part of the premiums we receive to our reinsurers and collect cash back when losses subject to our reinsurance coverage are paid.

The timing of our cash flows from operating activities can vary among periods due to the timing by which payments are made or received. Some of our payments and receipts, including loss settlements and subsequent reinsurance receipts, can be significant, and as a result their timing can influence cash flows from operating activities in any given period. Management believes that cash receipts from premiums and proceeds from investment income are sufficient to cover cash outflows in the foreseeable future.

Our cash flows for the three months ended March 31, 2024 and 2023 were:

*($ in thousands)*

| Cash and cash equivalents provided by (used in): | 2024 | 2023 |
| --- | ---: | ---: |
| Operating activities | **$94,265** | $107,207 |
| Investing activities | **(69,866)** | (193,426) |
| Financing activities | **(9,466)** | 66,455 |
| **Change in cash and cash equivalents and restricted cash** | **$14,933** | $(19,764) |

The increase in cash provided by operating activities in 2024 and 2023 was primarily due to positive cash flow from our insurance operations. Cash from operations can vary from period to period due to the timing of premium receipts, claim payments and reinsurance activity. Cash flows from operations in each of the past two years were used primarily to fund investing activities.

Net cash used in investing activities in 2024 and 2023 was primarily driven by purchases of fixed maturity securities and short-term investments.

Net cash used in financing activities in 2024 was driven by net payments on debt.

### Credit Agreements

#### Revolving Credit Facility

On March 29, 2023, we entered into an unsecured revolving credit facility (the “Revolving Credit Facility”) with a syndicate of participating banks. The Revolving Credit Facility provides us with up to a $150.0 million revolving credit facility, with an accordion that can increase the capacity by $50.0 million, and a letter of credit sub-facility of up to $30.0 million.

On March 14, 2024, we drew $50.0 million on the Revolving Credit Facility and used the proceeds and existing cash to fund the redemption of the Debentures (see “Debentures” below for additional information regarding the redemption). As of March 31, 2024, we had $100.0 million outstanding under the Revolving Credit Facility with another $50.0 million of undrawn capacity.

Interest on the Revolving Credit Facility is payable quarterly. The interest rate on the Revolving Credit Facility is the SOFR plus a margin of between 150 and 190 basis points based on the ratio of debt to total capital and a credit spread adjustment of 10 basis points. The following table sets forth the outstanding draws on the Revolving Credit Facility as of March 31, 2024:

*($ in thousands)*

|  | Amount | Margin | March 31, 2024 Six-month SOFR | Net interest rate |
| --- | ---: | ---: | ---: | ---: |
| March 15, 2024 | $50,000 | 1.60% | 5.25% | 6.85% |
| March 29, 2023 | $50,000 | 1.60% | 5.23% | 6.83% |

We are subject to covenants on the Revolving Credit Facility based on minimum net worth, maximum debt to capital ratio, minimum A.M. Best Rating and minimum liquidity. As of March 31, 2024, we are in compliance with all covenants.

#### Debentures

In August 2006, we received $58.0 million of proceeds from a debenture offering through a statutory trust, Delos Capital Trust (the “Trust”). The sole asset of the Trust consists of Fixed/Floating Rate Junior Subordinated Deferrable Interest Debentures (the “Trust Preferred”) with a principal amount of $59.8 million issued by us and cash of $1.8 million from the issuance of Trust common shares purchased by us equal to 3% of the Trust capitalization. On March 15, 2024, the Company redeemed the Debentures and paid $1.4 million of accrued interest.

#### Subordinated Debt

In May 2019, we issued unsecured subordinated notes (the “Notes”) with an aggregate principal amount of $20.0 million. Interest on the subordinated notes is 7.25% fixed for the first eight years and 8.25% fixed thereafter. Early retirement of the debt ahead of the eight-year commitment requires all interest payments to be paid in full, as well as the return of all capital. Principal payment is due at maturity on May 24, 2039 and interest is payable quarterly.

At March 31, 2024 the ratio of total debt outstanding, including the Revolving Credit Facility, the Trust Preferred and the Notes, to total capitalization (defined as total debt plus stockholders’ equity) was 14.7% and at December 31, 2023, the ratio of total debt outstanding, including the Term Loan, the Revolver, the Trust Preferred and the Notes, to total capitalization was 16.3%.

### Reinsurance

We strategically purchase reinsurance from third parties which enhances our business by protecting capital from severity events (either large single event losses or catastrophes) and reducing volatility in our earnings. Our reinsurance contracts are predominantly one year in length and renew annually throughout the year. At each annual renewal, we consider several factors that influence any changes to our reinsurance purchases, including any plans to change the underlying insurance coverage we offer, updated loss activity, the level of our capital and surplus, changes in our risk appetite and the cost and availability of reinsurance treaties.

We purchase quota share reinsurance, excess of loss reinsurance, and facultative reinsurance coverage to limit our exposure from losses on any one occurrence. The mix of reinsurance purchased considers efficiency, cost, our risk appetite and specific factors of the underlying risks we underwrite.

- ***Quota share reinsurance*** refers to a reinsurance contract whereby the reinsurer agrees to assume a specified percentage of the ceding company’s losses arising out of a defined class of business in exchange for a corresponding percentage of premiums, net of a ceding commission.
- ***Excess of loss reinsurance*** refers to a reinsurance contract whereby the reinsurer agrees to assume all or a portion of the ceding company’s losses for an individual claim or an event in excess of a specified amount in exchange for a premium payable amount negotiated between the parties, which includes our catastrophe reinsurance program.
- ***Facultative coverage*** refers to a reinsurance contract on individual risks as opposed to a group or class of business. It is used for a variety of reasons, including supplementing the limits provided by the treaty coverage or covering risks or perils excluded from treaty reinsurance.

For the three months ended March 31, 2024 our net retention on a written basis (calculated as net written premiums as a percentage of gross written premiums) was 62.6%, compared to 56.1% for the same 2023 period.

The following is a summary of our reinsurance programs as of March 31, 2024:

| Line of Business | Maximum Company Retention |
| --- | --- |
| Accident & Health | $0.90 million per occurrence |
| Commercial Auto(1) | $1.00 million per occurrence |
| Cyber | $2.69 million per occurrence |
| Excess Casualty(1)(2) | $1.25 million per occurrence |
| General Liability(1) | $1.50 million per occurrence |
| Professional Lines(2) | $5.21 million per occurrence |
| Property(3) | $2.80 million per occurrence |
| Representation and Warranty | $3.25 million per occurrence |
| Surety(2) | $3.00 million per occurrence |
| Workers’ Compensation(2) | $2.33 million per occurrence |
| (1) Legal defense expenses can force exposure above the maximum company retention for Excess Casualty, Commercial Auto and General Liability. |  |
| (2) Reinsurance is subject to a loss ratio cap or aggregate level of loss cover that exceeds a modeled 1:250-year PML event. |  |
| (3) Catastrophe loss protection is purchased up to $28.0 million in excess of $12.0 million retention, which provides cover for a 1:250-year PML event. |  |

### Credit and Financial Strength Ratings

On August 25, 2023, A.M. Best affirmed Skyward Specialty’s financial strength rating of A- (Excellent) and revised the outlook to positive from stable.

## Market risk

As filed, 152 characters.

There have been no material changes in market risk from the information provided in our Annual Report on Form 10-K for the year ended December 31, 2023.

## Controls and procedures

As filed, 1,505 characters.

#### Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in the reports we file under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), as appropriate, to allow timely decisions regarding required financial disclosure. In connection with the preparation of this quarterly report on Form 10-Q, our management carried out an evaluation, under the supervision and with the participation of our management, including the CEO and CFO, as of March 31, 2024, of the effectiveness of the design and operation of our disclosure controls and procedures, as such term is defined under Rule 13a-15(e) and 15d-15(e) under the Exchange Act. Based upon this evaluation, our CEO and CFO concluded that our disclosure controls and procedures were effective as of March 31, 2024.

#### Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) during the last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 184 characters.

There have been no material changes in our risk factors in the quarter ended March 31, 2024 from those disclosed in our Annual Report on Form 10-K for the year ended December 31, 2023.

Filed May 3, 2024.
Source: SEC EDGAR, the filing index for accession 0001519449-24-000024. Last ingested by Listed: Nov 11, 2026, 03:15 ET. No prices; not investment advice.
